His research focusses on the roles of B cells in the development of systemic autoimmune diseases and on the optimization of the immunotherapies for autoimmunity and cancers. The LBAI is actively involved in several European research programs (H2020 HarmonicSS, IMI PRECISESADS, IMI2 NECESSITY, IMI2 3TR) and has active collaborations with several groups in the USA.